SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

ABCL

AbCellera Biologics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 9h ago SEC0001193125-26-460670
Passive stake amendment
Actionable Insight • Neutral

CEO's stake is unchanged and passive; no signal of insider conviction change. Monitor next 10-Q for any insider trading activity or stake adjustments.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Carl Hansen filed an amended Schedule 13G/A disclosing a 19.7% beneficial ownership stake in AbCellera as of September 30, 2026, unchanged from the prior filing. The filing is a routine periodic update with no change in position.

Key Financial Metrics

Stake
19.7%
Investor
Carl L.G. Hansen

Key Facts

  • Carl L.G. Hansen beneficially owns 65,913,149 common shares (19.7% of outstanding) as of September 30, 2026
  • Thermopylae Holdings Ltd., wholly owned by Hansen, directly holds 56,134,097 shares (17.2%)
  • Hansen's stake includes 898,000 shares held directly and 8,881,052 shares issuable on option exercise within 60 days
  • Stake is unchanged from the prior SC 13G/A filed May 7, 2026

Financial Impact

No change in stake; no financial impact

Risk Factors

  • No material risk identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001193125-26-460670
Document: 0001193125-26-460670-index.html0001193125-26-460670
Document: 0001193125-26-460670.txt0001193125-26-460670

Track record

16 reports on ABCL

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +127.09% at T+20 after the Jul 29, 2026 report. 7 of 10 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $11.63 Now $11.12 −4.39% settles Feb 12
  2. Nov 13, 20263d ago Insider Cluster Bullish 4/10 Entry $11.49 Now $11.12 −3.22% settles Feb 11
  3. Nov 13, 20263d ago Insider Cluster Bullish 4/10 Entry $11.49 Now $11.12 −3.22% settles Feb 11
  4. Nov 9, 20267d ago 8-K Neutral 5/10 Entry $12.46 Now $11.12 −10.75% settles Feb 8
  5. Aug 24, 202612w ago Insider Cluster Mixed 5/10 Entry $12.50 Now $11.12 −11.04% settles Nov 18
  6. Aug 18, 202612w ago Insider Cluster Bullish 5/10 Entry $11.12 to $11.95 Now $11.12 −0.00% ▲ +7.46% +8.46% vs SPY
  7. Aug 15, 202613w ago Institutional Cluster Bearish 6/10 Entry $11.20 to $12.46 Now $11.12 +0.71% ▼ −11.25% −14.19% vs SPY
  8. Aug 11, 202613w ago 424B5 Bearish 7/10 Entry $10.36 to $11.13 Now $11.12 −7.39% ▼ −7.48% −12.60% vs SPY
  9. Aug 10, 202614w ago 8-K Bullish 7/10 Entry $9.34 to $12.18 Now $11.12 +19.06% ▲ +30.41% +32.82% vs SPY
  10. Jul 29, 202615w ago 8-K Bullish 6/10 Entry $5.39 to $11.37 Now $11.12 +106.31% ▲ +110.95% +106.22% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 7h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026